336 related articles for article (PubMed ID: 27758890)
1. Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth.
Lin HP; Cheng ZL; He RY; Song L; Tian MX; Zhou LS; Groh BS; Liu WR; Ji MB; Ding C; Shi YH; Guan KL; Ye D; Xiong Y
Cancer Res; 2016 Dec; 76(23):6924-6936. PubMed ID: 27758890
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-CoA-mediated autoacetylation of fatty acid synthase as a metabolic switch of de novo lipogenesis in
Miao T; Kim J; Kang P; Fujiwara H; Hsu FF; Bai H
Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2212220119. PubMed ID: 36459649
[TBL] [Abstract][Full Text] [Related]
3. Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?
Lupu R; Menendez JA
Endocrinology; 2006 Sep; 147(9):4056-66. PubMed ID: 16809439
[TBL] [Abstract][Full Text] [Related]
4. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW
Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855
[TBL] [Abstract][Full Text] [Related]
5. Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.
Li L; Che L; Tharp KM; Park HM; Pilo MG; Cao D; Cigliano A; Latte G; Xu Z; Ribback S; Dombrowski F; Evert M; Gores GJ; Stahl A; Calvisi DF; Chen X
Hepatology; 2016 Jun; 63(6):1900-13. PubMed ID: 26910791
[TBL] [Abstract][Full Text] [Related]
6. FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth.
Wei W; Qin B; Wen W; Zhang B; Luo H; Wang Y; Xu H; Xie X; Liu S; Jiang X; Wang M; Tang Q; Zhang J; Yang R; Fan Z; Lyu H; Lin J; Li K; Lee MH
Signal Transduct Target Ther; 2023 May; 8(1):187. PubMed ID: 37202390
[TBL] [Abstract][Full Text] [Related]
7. Histone modifications in fatty acid synthase modulated by carbohydrate responsive element binding protein are associated with non‑alcoholic fatty liver disease.
Cai C; Yu H; Huang G; Du X; Yu X; Zhou Y; Shen W
Int J Mol Med; 2018 Sep; 42(3):1215-1228. PubMed ID: 29786745
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers.
Uddin S; Siraj AK; Al-Rasheed M; Ahmed M; Bu R; Myers JN; Al-Nuaim A; Al-Sobhi S; Al-Dayel F; Bavi P; Hussain AR; Al-Kuraya KS
J Clin Endocrinol Metab; 2008 Oct; 93(10):4088-97. PubMed ID: 18682509
[TBL] [Abstract][Full Text] [Related]
9. Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells.
Jiang L; Fang X; Wang H; Li D; Wang X
Front Immunol; 2018; 9():2927. PubMed ID: 30619288
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors.
Angeles TS; Hudkins RL
Expert Opin Drug Discov; 2016 Dec; 11(12):1187-1199. PubMed ID: 27701891
[TBL] [Abstract][Full Text] [Related]
11. P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth.
Gang X; Yang Y; Zhong J; Jiang K; Pan Y; Karnes RJ; Zhang J; Xu W; Wang G; Huang H
Oncotarget; 2016 Mar; 7(12):15135-49. PubMed ID: 26934656
[TBL] [Abstract][Full Text] [Related]
12. FASN-dependent de novo lipogenesis is required for brain development.
Gonzalez-Bohorquez D; Gallego López IM; Jaeger BN; Pfammatter S; Bowers M; Semenkovich CF; Jessberger S
Proc Natl Acad Sci U S A; 2022 Jan; 119(2):. PubMed ID: 34996870
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis.
Lee KH; Lee MS; Cha EY; Sul JY; Lee JS; Kim JS; Park JB; Kim JY
Mol Med Rep; 2017 Apr; 15(4):2163-2173. PubMed ID: 28260110
[TBL] [Abstract][Full Text] [Related]
14. Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer.
Zaytseva YY; Elliott VA; Rychahou P; Mustain WC; Kim JT; Valentino J; Gao T; O'Connor KL; Neltner JM; Lee EY; Weiss HL; Evers BM
Carcinogenesis; 2014 Jun; 35(6):1341-51. PubMed ID: 24510238
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.
Zaytseva YY; Rychahou PG; Gulhati P; Elliott VA; Mustain WC; O'Connor K; Morris AJ; Sunkara M; Weiss HL; Lee EY; Evers BM
Cancer Res; 2012 Mar; 72(6):1504-17. PubMed ID: 22266115
[TBL] [Abstract][Full Text] [Related]
16. Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma.
Che L; Pilo MG; Cigliano A; Latte G; Simile MM; Ribback S; Dombrowski F; Evert M; Chen X; Calvisi DF
Cell Cycle; 2017 Mar; 16(6):499-507. PubMed ID: 28118080
[TBL] [Abstract][Full Text] [Related]
17. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.
Goswami S; Sharma-Walia N
Oncotarget; 2016 Sep; 7(37):58953-58974. PubMed ID: 27270654
[TBL] [Abstract][Full Text] [Related]
19. Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer.
Gonzalez-Guerrico AM; Espinoza I; Schroeder B; Park CH; Kvp CM; Khurana A; Corominas-Faja B; Cuyàs E; Alarcón T; Kleer C; Menendez JA; Lupu R
Oncotarget; 2016 Nov; 7(44):71151-71168. PubMed ID: 27223424
[TBL] [Abstract][Full Text] [Related]
20. Increased HAGLR expression promotes non-small cell lung cancer proliferation and invasion via enhanced de novo lipogenesis.
Lu C; Ma J; Cai D
Tumour Biol; 2017 Apr; 39(4):1010428317697574. PubMed ID: 28443464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
